Article info

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

Authors

  1. Correspondence to Dr Zeynep Eroglu; zeynep.eroglu{at}moffitt.org
View Full Text

Citation

Eroglu Z, Broman KK, Thompson JF, et al
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

Publication history

  • Accepted June 21, 2022
  • First published August 24, 2022.
Online issue publication 
November 15, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.